November, 2017

All the posts published.

ProAxsis Announces Sales Acceleration of its CE Marked Active Neutrophil Elastase Immunoassay

Nov 21, 2017
-
News, ProAxsis, RNS Announcements
London, UK – 21 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes the announcement by its portfolio company, ProAxsis, which today provides an update on sales of its ProteaseTag® Active Neutrophil Elastase Immunoassay (NEIA). ProAxsis forecasts direct sales of the NEIA to increase by a factor of three in [...]

Vortex Biosciences Announces First Commercial Sale of the VTX-1 Liquid Biopsy System

Nov 7, 2017
-
News, RNS Announcements
London, UK – 7 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes that its portfolio company, Vortex BioSciences, today announced its first direct commercial sale of its VTX-1 Liquid Biopsy System, a fully automated benchtop system for collecting intact Circulating Tumour Cells (CTCs).   Vortex’s VTX-1 Liquid Biopsy System [...]

Health Resource Solutions Expands Use of Wanda to All Patients

Nov 3, 2017
-
News, RNS Announcements
London, UK – November 3rd 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that HRS Home Health (HRS) is expanding their use of Wanda to all of their home health patients. This follows a successful trial evaluation involving high-risk, co-morbid Congestive Heart Failure patients.   Commenting on the news, NetScientific’s [...]

Glycotest™ Further Strengthens its Intellectual Property Portfolio with an Allowed Chinese Patent

Nov 2, 2017
-
Glycotest, News, RNS Announcements
London, UK – 02 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that a Chinese patent exclusively licensed to one of its portfolio companies, Glycotest, has been allowed. The patent provides broad protection of the assays in Glycotest’s HCC Panel test for early-stage hepatocellular carcinoma (HCC) and the Company’s [...]

Vortex Biosciences Announces Publication of Liquid Biopsy Study in Nature Partner Journals Genomic Medicine

Nov 1, 2017
-
News, RNS Announcements
London, UK – 1 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update from its portfolio company, Vortex BioSciences, which today announced the publication of “Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection” in Nature Partner Journals (npj) Genomic Medicine on 1 [...]
November 2017 - NetScientific